Abstract
A differential pulse polarographic (DPP) assay was developed to measure the stability kinetics of dipotassium clorazepate at 37°C in various aqueous buffers and in whole blood, and to characterize its transfer across the everted intestinal sac preparation. Employing a differential extraction procedure along with DPP, it was possible to quantify dipotassium clorazepate and desmethyldiazepam, its major degradation product, and qualitatively identify a minor degradation product, 2-amino-5-chlorobenzophenone. The in vitro stability data indicate that the rate of degradation decreases with an increase in pH, with relatively instantaneous breakdown below pH 4 and relative stability at pH 7.4. Permeability across the everted sac preparation at pH 1.5 reflects instantaneous degradation and transfer of the degradation product, desmethyldiazepam. At pH 7.4, negligible desmethyldiazepam is formed and transferred across the sac preparation. In addition, the permeability profile of intact dipotassium clorazepate suggests a potential for permeability rate limited intestinal absorption. Overall, the data suggest that if dipotassium clorazepate is administered so that it bypasses the more favorable acidic pH environment for biodegradation, one should anticipate variable absorption, physiological disposition, and clinical profiles as a function of route of administration and dosage form.
Similar content being viewed by others
References
J. Schmitt, P. Comoy, M. Suguet, G. Calief, J. Le Muer, T. Clim, M. Brunaud, J. Salle, and G. Srov. Sur des nouvelles benzodiazepines hydrosolubles douées d'une puissante activité sur le système nerveux central.Chim. Ther. 4:239 (1969).
P. Gros and R. Raveux. Etude de l'excretion du Clorazepate dipotassique et de ses métabolites urinaires. I. Fractionnement identification et dosage des metabolites urinaires.Chim. Ther. 4:312 (1969).
A. Viala, J. P. Cano, and A. Angeletti-Philippe. Recherche toxicologique des benzodiazepines dans le sang et l'urine: Importance de leurs transformation metaboliques.Eur. J. Toxicol. 3:197 (1971).
H. Oelschlager and F. I. Sengun. Gehaltsbestimmung von Dikabumchlorazepat Mitt. Arzneimittellanalyses mittels Polarographie oder Oszillopolarographie.Arch. Pharm. 307:401 (1974).
M. A. Brooks and J. A. F. de Silva. Determination of 1,4-benzodiazepines in biological fluids by differential pulse polarography.Talanta, 849 (1975).
J. A. F. de Suva and M. R. Hackman. Determination of glibornuride (a tolysulfonyl urea hypoglycemie agent) in blood by differential pulse polarography.Anal. Chem. 44:1145 (1972).
S. A. Kaplan and S. Cotler. Use of cannulated everted intestinal sac for serial sampling as a drug absorbability (permeability) screen.J. Pharm. Sci. 61:1361 (1972).
R. Raveux, P. Gros, and J. Navarro. Etude de l'excretion du Clorazepate dipotassique et de ses métabolites urinaires. II. Experimentation chez le chien après administrations intraveineuse, intraduodinale et orale.Chim. Ther. 4:357 (1969).
R. Raveux and P. Gros. Etude de l'excretion du Clorazepate dipotassique et de ses métabolites urinaires. III. Experimentation chez l'homme après administration en comprimes intereques et en gelules.Chim. Ther. 4:481 (1969).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Abruzzo, C.W., Brooks, M.A., Cotler, S. et al. Differential pulse polarographic assay procedure andin vitro biopharmaceutical properties of dipotassium clorazepate. Journal of Pharmacokinetics and Biopharmaceutics 4, 29–41 (1976). https://doi.org/10.1007/BF01271442
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01271442